Ardelyx
ARDX4.02017.45% ( -0.850 )
Ardelyx (ARDX)
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSREL...
- Open
- 4.075
- High
- 4.270
- Low
- 3.950
- Prev. Close
- 4.870
- Volume
- 1.44M
- Turnover
- 5.86M
- Avg Price
- 4.084
- Bid/Ask Ratio
- --
- Amplitude
- 6.57%
- 52wk High
- 8.400
- Volume Ratio
- 106.18
- Turnover Ratio
- 0.65%
Ardelyx Analyst Rating
View MoreForecast & Rating
Aug 7, 2026Price forecast
$15.60288.06%
Forecast & RatingStrong buy
11analysts
- Strong buy90.91%
- Buy9.09%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Stock Invest · 1 hour ago
Ardelyx Shares Take a Hit After Q2 Earnings Miss and Slashed Revenue Forecast
- benzinga_article · 1 hour ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga_article · 1 hour ago
Trade Desk Posts Downbeat Q2 Results, Joins Sezzle, Resmed, Ouster And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
- Market Beat · 9 hours ago
Ardelyx (NASDAQ:ARDX) Announces Quarterly Earnings Results
- benzinga_article · 16 hours ago
12 Health Care Stocks Moving In Thursday's After-Market Session
- Earnings Watch · 16 hours ago
Ardelyx | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 120.88 M
